3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice
Journal of Medicinal Chemistry2008Vol. 51(16), pp. 5101–5108
Citations Over TimeTop 1% of 2008 papers
Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui, Young‐Jun Shin, Jae‐Kyu Jung, Martin C. Cherrier, Peter J. Webb, Susan Y. Tamura, P. Douglas Boatman, Carleton R. Sage, Thomas O. Schrader, Ruoping Chen, Steven L. Colletti, James R. Tata, M. Gerard Waters, Kang Cheng, Andrew K.P. Taggart, Tian‐Quan Cai, Ester Carballo‐Jane, Dominic P. Behan, Daniel T. Connolly, Jeremy G. Richman
Abstract
The discovery and profiling of 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (5a, MK-0354), a partial agonist of GPR109a, is described. Compound 5a retained the plasma free fatty acid lowering effects in mice associated with GPR109a agonism, but did not induce vasodilation at the maximum feasible dose. Moreover, preadministration of 5a blocked the flushing effect induced by nicotinic acid but not that induced by PGD2. This profile made 5a a suitable candidate for further study for the treatment of dyslipidemia.
Related Papers
- → Cytisine-Based Nicotinic Partial Agonists as Novel Antidepressant Compounds(2009)75 cited
- → (+)-Laburnamine, a Natural Selective Ligand and Partial Agonist for the α4β2 Nicotinic Receptor Subtype(2013)16 cited
- → N-Terminal Domains in Mouse and Human 5-Hydroxytryptamine3A Receptors Confer Partial Agonist and Antagonist Properties to Benzylidene Analogs of Anabaseine(2006)11 cited
- → AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors(2015)9 cited
- → In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT4 receptor(2009)5 cited